In summary, PBT has emerged as a standard external beam RT modality with potential advantages over conventional photon therapy for the treatment of some patients with gastrointestinal cancers. In this special issue of the Journal of Gastrointestinal Oncology, we will provide a comprehensive review of the rationale, clinical data, current indications, and future directions for the use of PBT for gastrointestinal cancers.
Editorial
A brief overview of the use of proton beam radiotherapy for gastrointestinal cancers
Review Article
The emerging role of proton therapy for esophagus cancer
Proton beam therapy for liver cancers
Proton beam radiotherapy for pancreas cancer
Proton beam radiotherapy for anal and rectal cancers
Original Article
Proton beam re-irradiation for gastrointestinal malignancies: a systematic review
Review Article
Heavy charged particles for gastrointestinal cancers
Managing treatment-related uncertainties in proton beam radiotherapy for gastrointestinal cancers
Radiation biology considerations of proton therapy for gastrointestinal cancers
Disclosure:
The series “Proton Beam Radiotherapy for Gastrointestinal Cancers” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Christopher L. Hallemeier, Jonathan B. Ashman and Michael G. Haddock served as the unpaid Guest Editors for the series.